The DASH diet was shown to lower blood pressure decades ago, yet few people follow it. Here’s how to give it a try.

In this segment of The Expert Series, Laura Coleman, PhD, RD provides insight on Lupus & Diet: Separating Fact from Fiction. You will learn about common beliefs and whether they are fact or fiction.

Panelists discuss the updated treatment recommendations for lupus nephritis in the Kidney Disease Improving Global Outcomes and European Alliance of Associations for Rheumatology guidelines ...

In the past decade significant contributions have been made to the understanding of acute glomerulonephritis by virtue of advances in many fields, including epidemiology, immunology ...

Lifestyle Modifications and Integrated Care: Encouraging lifestyle modifications can significantly impact the management of CKD and diabetic nephropathy. A diet low in sodium, processed foods, and ...

Objective: Examine strategies for early diagnosis/screening, updated treatment guidelines, and treatment and payer considerations to optimize lupus nephritis management and address patient access ...

Idiopathic crescentic glomerulonephritis (GN ... In this article, evidence-based recommendations for management are presented. Because of the high risk of end-stage renal disease (ESRD), early ...

After collecting a handful of oncology approvals since its first leukemia nod in 2013, Roche’s Biogen-partnered Rituxan successor, Gazyva, is chasing new horizons in active lupus nephritis.

Genentech announced positive results from the Phase III study (REGENCY) of Gazyva (Obinutuzumab) for people with active lupus nephritis (LN). Gazyva is an engineered humanized monoclonal antibody ...

If your healthcare provider suspects you may have diabetes-related nephropathy, they may order tests. “Successfully managing diabetes and chronic kidney disease simultaneously requires practical ...

“We are thrilled to achieve this milestone that will provide access to LUPKYNIS in Japan, where there is a high rate of lupus nephritis among Japanese lupus patients. Our successful strategic ...